Babu Lal Jangir
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Babu Lal Jangir has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Rekha Rao
Department of Pharmaceutical sciences, Guru Jambheshwar University of science and Technology, Hisar 125001, India
3 shared publications - Sunil Kumar
Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, India
3 shared publications - Varsha Kadian
Department of Pharmaceutical sciences, Guru Jambheshwar University of science and Technology, Hisar 125001, India
2 shared publications - Anroop Balachandran Nair
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
1 shared publication Maneesh Sharma
Department of Veterinary Clinical Complex, College of Veterinary Sciences, Lala Lajpat Rai University of Veterinary and Animal Science, Hisar, India
1 shared publication- Pooja Dalal
Department of Pharmaceutical sciences, Guru Jambheshwar University of science and Technology, Hisar 125001, India
1 shared publication
Latest Publications
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Micro and Nanosystems
- Vol. 18, 1-16
Improved Efficacy of Dithranol by Cyclodextrin Nanosponge Integrated Hydrogel for Psoriasis Topical Therapy
Introduction:: Psoriasis is a serious skin ailment that negatively impacts the daily lives of approximately 3% of people worldwide. To address patient treatment withdrawal due to associated side effects and the high cost of existing therapies, the aim of the present study was to fabricate a novel topical nanoformulation consisting of a dithranol-loaded nanosponge integrated hydrogel (DTHNS-HG) for the management of psoriasis. Dithranol (DTH) has low topical bioavailability due to its physicochemical determinants. Additionally, its clinical use is associated with some adverse effects, like irritation, burning, and staining. Methods:: To enhance topical effectiveness, DTH-loaded nanosponge-based hydrogels (DTHNSHG) were fabricated and evaluated. In this study, we evaluated in vitro irritation, in vivo skin targeting, and antipsoriatic activity using imiquimod induced mouse model, including oxidative stress markers in Swiss mice. Results:: In the present study, the DTH nanoparticulate hydrogel induced slight irritation and was found to be safe for topical application. This DTH hydrogel formed a depot in the epidermis, which was confirmed by in vivo skin distribution assessment using a fluorescent marker. Further, these experiments presented improved antipsoriatic efficacy in terms of histopathological, phenotypical, and biochemical assessments compared to the conventional product. DTHNS-HG successfully reduced PASI in psoriasis animal models, demonstrating the significant therapeutic potential of this nanoformulation in psoriasis. Discussion:: The anti-psoriatic potential of DTH in Swiss mice was greatly improved by its encapsulation in nanosponge-based hydrogels, which boosted its accumulation and diffusion into the skin. This was corroborated by the highest statistically significant reduction in PASI score, erythema, scaling, and skin thickness. In addition to the above, it was also seen that the skin histopathology of mice when administered DTHNS-HG exhibited reduced psoriasis lesions. Conclusion:: In summary, these findings suggest that the explored strategy may be a viable means of developing topical formulations for targeting the skin and achieving stronger anti-psoriatic effects with minimum skin irritation. These outcomes may potentially contribute to supporting experimental confirmation of the clinical utility of DTHNS-HG in psoriasis management.
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Micro and Nanosystems
- Vol. 18, 1-16
Improved Efficacy of Dithranol by Cyclodextrin Nanosponge Integrated Hydrogel for Psoriasis Topical Therapy
Introduction:: Psoriasis is a serious skin ailment that negatively impacts the daily lives of approximately 3% of people worldwide. To address patient treatment withdrawal due to associated side effects and the high cost of existing therapies, the aim of the present study was to fabricate a novel topical nanoformulation consisting of a dithranol-loaded nanosponge integrated hydrogel (DTHNS-HG) for the management of psoriasis. Dithranol (DTH) has low topical bioavailability due to its physicochemical determinants. Additionally, its clinical use is associated with some adverse effects, like irritation, burning, and staining. Methods:: To enhance topical effectiveness, DTH-loaded nanosponge-based hydrogels (DTHNSHG) were fabricated and evaluated. In this study, we evaluated in vitro irritation, in vivo skin targeting, and antipsoriatic activity using imiquimod induced mouse model, including oxidative stress markers in Swiss mice. Results:: In the present study, the DTH nanoparticulate hydrogel induced slight irritation and was found to be safe for topical application. This DTH hydrogel formed a depot in the epidermis, which was confirmed by in vivo skin distribution assessment using a fluorescent marker. Further, these experiments presented improved antipsoriatic efficacy in terms of histopathological, phenotypical, and biochemical assessments compared to the conventional product. DTHNS-HG successfully reduced PASI in psoriasis animal models, demonstrating the significant therapeutic potential of this nanoformulation in psoriasis. Discussion:: The anti-psoriatic potential of DTH in Swiss mice was greatly improved by its encapsulation in nanosponge-based hydrogels, which boosted its accumulation and diffusion into the skin. This was corroborated by the highest statistically significant reduction in PASI score, erythema, scaling, and skin thickness. In addition to the above, it was also seen that the skin histopathology of mice when administered DTHNS-HG exhibited reduced psoriasis lesions. Conclusion:: In summary, these findings suggest that the explored strategy may be a viable means of developing topical formulations for targeting the skin and achieving stronger anti-psoriatic effects with minimum skin irritation. These outcomes may potentially contribute to supporting experimental confirmation of the clinical utility of DTHNS-HG in psoriasis management.
- 13 November 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-19
Novel Capsaicin Nanogel for Arthritic Pain and Inflammation Management: Formulation, In Vitro, Ex-vivo and In Vivo Assessment
The present work aimed to prepare and evaluate novel capsaicin (CAP) loaded nanosponges (NS) embedded Carbopol hydrogel (CAPNS-HG) with rosemary oil (RO) f
- 13 November 2025
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 27 (1) , 1-19
Novel Capsaicin Nanogel for Arthritic Pain and Inflammation Management: Formulation, In Vitro, Ex-vivo and In Vivo Assessment
The present work aimed to prepare and evaluate novel capsaicin (CAP) loaded nanosponges (NS) embedded Carbopol hydrogel (CAPNS-HG) with rosemary oil (RO) f
- 15 May 2024
- Published by Springer Nature in BioNanoScience
- Vol. 14 (2) , 1749-1766
Novel Topical Clobetasol Propionate Nanosponges Loaded Hydrogel For Psoriasis: Irritation Evaluation, Mechanistic Insights, in Vivo Appraisal and Biochemical Investigations
- 15 May 2024
- Published by Springer Nature in BioNanoScience
- Vol. 14 (2) , 1749-1766
Novel Topical Clobetasol Propionate Nanosponges Loaded Hydrogel For Psoriasis: Irritation Evaluation, Mechanistic Insights, in Vivo Appraisal and Biochemical Investigations
- 2 February 2022
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 97 (6) , 461-472
Acceleration of wound healing by quercetin in diabetic rats requires mitigation of oxidative stress and stimulation of the proliferative phase
Increased oxidative stress in diabetic wound areas impairs wound healing. Quercetin exhibits significant antioxidant properties. We investigated the effects of topical quercetin on antioxidant status in diabetic wound areas and its effect on wound healing in rats. A 2 cm2 cutaneous wound was produced on the back of streptozotocin induced diabetic and normal rats. Rats were divided into three groups of 20: normal healthy control group, diabetic group and quercetin treated diabetic group. The control and diabetic groups were treated topically with ointment base once daily for 21 days. The quercetin treated diabetic rats were treated similarly with ointment containing quercetin. The quercetin treated diabetic group exhibited increased levels of catalase, glutathione peroxidase, superoxide dismutase and total thiols compared to the diabetic group. Nitrite levels in the diabetic group were decreased significantly on day 3 compared to the healthy control group. Malondialdehyde levels were decreased in the quercetin treated diabetic group compared to the diabetic group. The expression of proliferating cell nuclear antigen) (PCNA) was greater in the quercetin treated diabetic group on day 7 compared to healthy control and diabetic groups. Formation of granulation tissue and the quality of healed tissue was improved in the quercetin treated diabetic group compared to the diabetic group. Quercetin improves antioxidant status in wounds of diabetic rats and stimulates the proliferation phase, which accelerates wound healing.
- 2 February 2022
- Published by Taylor & Francis in Biotechnic & Histochemistry
- Vol. 97 (6) , 461-472
Acceleration of wound healing by quercetin in diabetic rats requires mitigation of oxidative stress and stimulation of the proliferative phase
Increased oxidative stress in diabetic wound areas impairs wound healing. Quercetin exhibits significant antioxidant properties. We investigated the effects of topical quercetin on antioxidant status in diabetic wound areas and its effect on wound healing in rats. A 2 cm2 cutaneous wound was produced on the back of streptozotocin induced diabetic and normal rats. Rats were divided into three groups of 20: normal healthy control group, diabetic group and quercetin treated diabetic group. The control and diabetic groups were treated topically with ointment base once daily for 21 days. The quercetin treated diabetic rats were treated similarly with ointment containing quercetin. The quercetin treated diabetic group exhibited increased levels of catalase, glutathione peroxidase, superoxide dismutase and total thiols compared to the diabetic group. Nitrite levels in the diabetic group were decreased significantly on day 3 compared to the healthy control group. Malondialdehyde levels were decreased in the quercetin treated diabetic group compared to the diabetic group. The expression of proliferating cell nuclear antigen) (PCNA) was greater in the quercetin treated diabetic group on day 7 compared to healthy control and diabetic groups. Formation of granulation tissue and the quality of healed tissue was improved in the quercetin treated diabetic group compared to the diabetic group. Quercetin improves antioxidant status in wounds of diabetic rats and stimulates the proliferation phase, which accelerates wound healing.